Evidence map›Paper›PMID 42883424›Full record

ArticleBiology2026

Assessing the Small Nuclear Ribosomal Subunit (18S rRNA) as a Potential Barcoding Gene for Amphipoda (Malacostraca: Peracarida) Along with the Design of a Unique Primer Set to Target the Amphipod 18S rRNA Gene.

Thomas R Sawicki, Andrew G Cannizzaro, Joshua M Sisco

Abstract read
In one paragraph

Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Thomas R SawickiDepartment of Biological Sciences, Florida A&M University, Tallahassee, FL 32307, USA.ORCID 0000-0001-7087-3577
Andrew G CannizzaroDepartment of Biology, Miami University, Oxford, OH 45056, USA.ORCID 0000-0003-1280-1131
Joshua M SiscoDepartment of Biological Sciences, Florida A&M University, Tallahassee, FL 32307, USA.ORCID 0000-0002-0070-4433

Funding

United States Department of Education Title III
6 · The paper itself

Abstract

The mitochondrial cytochrome oxidase I (COI) gene is frequently used as a barcoding gene for the identification of numerous taxa, including crustaceans such as amphipods. The gene's variability, which makes it useful for barcoding, can also create primer annealing issues that can inhibit amplification and sequencing, and nuclear copies of mitochondrial DNA (NUMTs) can sometimes preferentially amplify over the mitochondrial COI target locus. The small nuclear ribosomal gene (18S rRNA) can overcome issues of amplification and sequencing as primers can be designed to target highly conserved regions, making it useful across a wide variety of taxa. Due to its conserved nature, the 18S rRNA gene has not been considered a strong candidate for barcoding. Peracarid crustaceans have an insertion within the V4 hypervariable region, and amphipods are unique amongst the peracarids with an additional insertion in the V5 hypervariable region, which could make this part of the gene large and variable enough to target for barcoding. Herein, we present three primer sets designed for Amphipoda that amplify the majority of the 18S rRNA gene, including one pair (18S450F-18S1500R) that captures the V4/V5 hypervariable regions. Analyses utilizing tree-building algorithms and two species delimitation models demonstrate the potential utility of the gene region amplified by the 18S450F-18S1500R primers for barcoding. The utility of this gene for barcoding will depend on researchers incorporating this locus into future species descriptions and phylogenetic studies.

Indexed as

COICrustaceacryptic speciesphylogenetics

Identifiers

PMID42883424
PMCPMC13664141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.